Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,161.2
-5.7 (-0.18%)

 

  • STI Straits Times Index
    3,161.2
    -5.7 (-0.18%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,493.0
    -1.6 (-0.11%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,235.8
    274.8 (1.06%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,464.3
    66.9 (1.97%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,781.0
    497.4 (1.82%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,096.5
    26.5 (0.44%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,145.9M
  • Value: 1,099.4M
  • Rise: 166
  • Fall: 177
  • Unch: 418

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.116+0.001
Rex Intl0.235+0.025
Abundance Intl0.046+0.004
Raffles Edu0.080-0.020
Genting Sing0.805-0.005
Mercurius0.057-0.004
KTL Global^0.122+0.004
YZJ Shipbldg SGD1.390+0.020
ISDN0.810+0.045
ThaiBev0.645-0.005

World Indices

World Indices
Name Last Change
Nasdaq 14,672.7 -105.6
HSI 26,235.8 +274.8
HSCEI 9,336.6 +103.4
Jakarta 6,096.5 +26.5
Nikkei 225 27,781.0 +497.4
SSE Comp 3,464.3 +66.9
Shanghai A 3,630.9 +70.2
Shanghai B 257.6 +3.6
KOSPI 3,223.0 +20.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PENUMBRA INC PENUMBRA
Updated on 30 Jul 2021 (End of trading day)
Last (USD): 266.230 Change: +1.800 High: 270.000 Remarks: -
Change (%): +0.68 Low: 262.460
Open 262.460 Yesterday's Close 264.43
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 168,722 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.43040 Trailing EPS (USD) e -0.14503 NAV (USD) b 17.9564
PE a - Trailing PE f - Price / NAV b 14.8265
Dividend (USD) d - Cash In Hand (USD) g 1.5249 Issued & Paid-up Shares c 36,482,400
Dividend Yield (%) d - Price / Cash In Hand g 174.588 Treasury Shares h -
Market Cap (M) 9,712.709 Enterprise Value (M) 9,542.264
Piotroski F Score 2 Exchange Code PEN Par Value ( $ ) n.a.
52 Weeks Volatility (%) 48.60 Free Float (%) 93.8
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Apr 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 14 Sep 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PENUMBRA INC NYSE 9,712.709 - - 14.8265 -
Industry Medical Specialties NYSE 42,752.490 46.740 35.601 7.3256 0.677
Local Peer ABBOTT LABORATORIES NYSE 214,959.684 48.057 33.847 - 1.261
Local Peer DANAHER CORP NYSE 212,378.111 60.507 60.507 5.3783 0.241
Local Peer THERMO FISHER SCIENTIFIC INC NYSE 212,239.050 33.292 24.690 5.7589 0.164
Local Peer MEDTRONIC PLC NYSE 176,467.509 48.937 48.937 3.4314 1.769
Local Peer STRYKER CORP NYSE 102,170.390 63.896 49.050 7.3929 0.867
Local Peer BECTON DICKINSON & CO NYSE 74,376.959 96.971 45.352 2.9962 1.232
Local Peer EDWARDS LIFESCIENCES CORP NYSE 69,791.186 84.760 71.735 - -
Local Peer BOSTON SCIENTIFIC CORP NYSE 64,793.496 - 138.448 - -
Local Peer AGILENT TECHNOLOGIES INC NYSE 46,496.571 64.668 50.267 9.6667 0.474
Local Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,237.050 31.214 31.529 2.9799 2.214
Local Peer RESMED INC NYSE 39,551.792 63.621 86.501 14.5989 0.571
Local Peer BAXTER INTERNATIONAL INC NYSE 38,668.039 35.089 47.041 - 1.247
Other Local Peers ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), BIO RAD LABORATORIES INC (NYSE), STERIS PLC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), QIAGEN NV (NYSE), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), HAEMONETICS CORP (NYSE), GLAUKOS CORPORATION (NYSE), AVANOS MEDICAL INC (NYSE), BUTTERFLY NETWORK INC (NYSE), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INVACARE CORP (NYSE)
Global Peer INTUITIVE SURGICAL INC NASDAQ 117,733.892 111.007 72.559 10.8636 -
Global Peer IDEXX LABORATORIES INC NASDAQ 57,865.513 99.463 85.828 82.3479 -
Global Peer ALIGN TECHNOLOGY INC NASDAQ 55,063.246 31.006 78.836 16.2697 -
Global Peer DEXCOM INC NASDAQ 49,875.025 101.043 106.639 - -
Global Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 29,590.316 40.668 34.707 9.3180 -
Global Peer INSULET CORPORATION NASDAQ 19,162.429 2,818.035 2,153.082 32.7395 -
Global Peer HOLOGIC INC NASDAQ 19,021.664 17.057 9.335 4.9061 -
Global Peer MICROPORT-1000 HKEx 129,916.930 - - - -
Global Peer NOVOCURE LTD NASDAQ 15,962.828 805.871 1,584.714 - -
Global Peer MASIMO CORPORATION NASDAQ 14,996.949 62.409 67.043 10.7796 -
Other Global Peers ABIOMED INC (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), MICROPORT-100 (HKEx), FISHER & PAYKEL HEALTHCARE CORP (ASX), BRUKER CORPORATION (NASDAQ), COCHLEAR LTD (ASX), ANGELALIGN (HKEx), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), HARTA (Bursa), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), INARI MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), INMODE LTD (NASDAQ), ICU MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), ATRICURE INC (NASDAQ), CARDIOFLOW-B (HKEx), EBOS GROUP (ASX), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), LIFETECH SCI (HKEx), THE BEAUTY HEALTH COMPANY (NASDAQ), SUPERMX (Bursa), CELLDEX THERAPEUTICS INC (NASDAQ), ZYLOXTB-B (HKEx), BIOLIFE SOLUTIONS INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), KANGJI MEDICAL (HKEx), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), PULMONX CORPORATION (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), EARGO INC (NASDAQ), AK MEDICAL (HKEx), NANO-X IMAGING LTD (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), NANOSONICS LIMITED (ASX), LEMAITRE VASCULAR INC (NASDAQ), ATRION CORP (NASDAQ), CIRC (HKEx), VIEWRAY INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CHUNLI MEDICAL (HKEx), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), BIOVENTUS INC (NASDAQ), CERUS CORP (NASDAQ), 908 DEVICES INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), AXOGEN INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), MODERN DENTAL (HKEx), TRANSMEDICS GROUP INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), KDL MEDICAL (HKEx), STEREOTAXIS INC (NYSE American), BASECARE-B (HKEx), PAVMED INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), NEUROPACE INC (NASDAQ), ZYNEX INC (NASDAQ), SIENTRA INC (NASDAQ), SOLITON INC (NASDAQ), ONCOCYTE CORP (NASDAQ), MISONIX INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), AVITA MEDICAL INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), IRADIMED CORP (NASDAQ), ACCURAY INCORPORATED (NASDAQ), LUCIRA HEALTH INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), CVRX INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), NEURONETICS INC (NASDAQ), YESTAR HEALTH (HKEx), CYTOSORBENTS CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), Medtecs Intl (SGX), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), UGHealthcare (SGX), DARIOHEALTH CORP (NASDAQ), CORMEDIX INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), INTRICOM CORP (NASDAQ), TELA BIO INC (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), INCANNEX HEALTHCARE LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), TITAN MEDICAL INC (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), ALPHA PRO TECH (NYSE American), NEMAURA MEDICAL INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), VENUS CONCEPT INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), FONAR CORP (NASDAQ), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), CHECK-CAP LTD (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), MICRO-X LTD (ASX), IRIDEX CORP (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), CELSION CORPORATION (NASDAQ), OPTISCAN IMAGING (ASX), AVINGER INC (NASDAQ), LENSAR INC (NASDAQ), KELFRED (HKEx), BIOLASE INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), NEUROMETRIX INC (NASDAQ), NEPHROS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), SDI LTD (ASX), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), AETHLON MEDICAL INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), ADVENTA (Bursa), EKSO BIONICS HOLDINGS INC (NASDAQ), YUNNAN ENERGY (HKEx), SENSUS HEALTHCARE INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), RESONANCE HEALTH LTD (ASX), NEOVASC INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), RGTBHD (Bursa), HANCOCK JAFFE LABORATORIES INC (NASDAQ), Biolidics (SGX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), KEWAUNEE SCIENTIFIC CORP (NASDAQ), LKL (Bursa), DAXOR CORP (NYSE American), RESPIRI LTD (ASX), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), Yunnan Energy (SGX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), ADHERIUM LIMITED (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), METALICITY LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE American), LIFE HEALTHCARE (HKEx), CYANOTECH CORP (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+4.140
+1.58 %
10 Days -+9.850
+3.84 %
20 Days --7.300
-2.67 %
Medium Term Return 3 Months --31.870
-10.69 %
6 Months -+12.370
+4.87 %
1 Year -+36.750
+16.01 %
Long Term Return 2 Years -+108.390
+68.67 %
3 Years -+118.180
+79.82 %
5 Years -+199.170
+297.00 %
Annualised Return Annualised --
+31.75 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 163.490 - 320.000 Change From 1 Year Low +102.740 % Change From 1 Year Low (%) +62.84
Change From 1 Year High -53.770 % Change From 1 Year High (%) -16.80
2 Years Range 121.800 - 320.000 Change From 2 Years Low +144.430 % Change From 2 Years Low (%) +118.58
Change From 2 Years High -53.770 % Change From 2 Years High (%) -16.80
5 Years Range 56.050 - 320.000 Change From 5 Years Low +210.180 % Change From 5 Years Low (%) +374.99
Change From 5 Years High -53.770 % Change From 5 Years High (%) -16.80
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers thrombectomy, embolization, access, neurosurgical tools, ruby coil system, lantern, penumbra occlusion device (POD) system, packing coil, and indigo systems products. Its target markets include interventional neuroradiologists, neurosurgeons, and interventional neurologists; and interventional radiologists, vascular surgeons, and interventional cardiologists. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004 and is headquartered in Alameda, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
30 Jul 2021 262.460 270.000 262.460 266.230 168,722 -
29 Jul 2021 262.510 270.260 261.860 264.430 160,962 -
28 Jul 2021 263.310 265.000 260.091 262.100 392,322 -
27 Jul 2021 261.560 261.645 256.090 261.230 119,581 -
26 Jul 2021 265.240 265.240 261.530 262.090 86,837 -
23 Jul 2021 268.480 271.430 265.240 266.400 154,140 -
22 Jul 2021 265.650 268.060 263.650 267.140 130,128 -
21 Jul 2021 263.870 265.780 259.010 264.660 241,253 -
20 Jul 2021 257.370 264.250 257.370 261.950 154,677 -
19 Jul 2021 250.600 258.370 250.280 256.380 118,853 -
16 Jul 2021 252.500 255.550 248.510 254.220 119,289 -
15 Jul 2021 250.940 253.940 249.020 250.720 127,400 -
14 Jul 2021 266.450 268.005 252.370 253.830 148,699 -
13 Jul 2021 270.000 271.030 263.610 264.110 91,697 -
12 Jul 2021 275.090 275.090 270.030 271.600 84,024 -
09 Jul 2021 273.780 277.600 271.640 276.550 78,071 -
08 Jul 2021 270.310 275.440 268.190 273.200 131,483 -
07 Jul 2021 278.200 279.350 273.460 275.370 80,150 -
06 Jul 2021 275.290 276.770 269.795 275.900 125,112 -
02 Jul 2021 277.250 277.250 271.500 273.530 81,353 -
01 Jul 2021 273.330 277.885 271.173 276.300 138,263 -
30 Jun 2021 275.620 279.600 272.950 274.060 130,015 -
Summary
Current 2 Weeks
(19 Jul 2021 to 30 Jul 2021)
250.600 271.430 250.280 266.230 1,727,475 -
Previous 2 Weeks
(02 Jul 2021 to 16 Jul 2021)
277.250 277.250 250.280 254.220 1,067,278 -
4 Weeks from
(04 Jun 2021 to 01 Jul 2021)
269.640 272.520 250.280 276.300 4,312,086 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.